Federico G.
- Country
- Italy
- Department
- 2400: S.O.D. Clinica di Cardiologia ed Aritmologia
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis [Lp(a)FRONTIERS CAVS]
- Evaluation of Dapagliflozin in Reducing Chemotherapy-Induced Cardiotoxicity in Breast Cancer Patients Receiving Anthracycline-Based Therapy
Data & Insights
Has run more than one trial at 77 of 605 partner sites.
Specializations
Cardiovascular Disease Management
This investigator specializes in studying calcific aortic valve stenosis, focusing on innovative therapeutic approaches to slow disease progression. Their research examines the effects of lipoprotein(a) lowering treatments on valve calcification processes.
- Aortic valve calcification
- Lipoprotein(a) metabolism
- Valve disease progression
Their work involves advanced imaging techniques including echocardiography and computed tomography to assess treatment outcomes.
Cardio-Oncology
The investigator explores the intersection of cardiac health and cancer treatment, with particular emphasis on chemotherapy-induced cardiotoxicity in breast cancer patients. Their research evaluates protective strategies using novel therapeutic agents.
- Cancer therapy cardiac complications
- Cardioprotective interventions
- SGLT-2 inhibitor applications
Their studies focus on preventing and managing cardiac complications in cancer treatment contexts.
Stroke Prevention
The investigator conducts research in stroke prevention for patients with atrial fibrillation, evaluating novel anticoagulation strategies. Their work encompasses comparative studies of different anticoagulant therapies for preventing stroke and systemic embolism.
- Atrial fibrillation management
- Anticoagulation therapy
- Bleeding risk assessment
Their research emphasizes both efficacy and safety profiles in stroke prevention treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.